Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edwin Clark
BRD4 Amplification Facilitates an Oncogenic Gene Expression Program in High-Grade Serous Ovarian Cancer and Confers Sensitivity to BET Inhibitors
PLoS ONE
Multidisciplinary
Identification of Candidate Predictive and Surrogate Molecular Markers for Dasatinib in Prostate Cancer: Rationale for Patient Selection and Efficacy Monitoring
Genome Biology
Related publications
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
New in High Grade Serous Ovarian Cancer Treatment
Effective Pharmacotherapy
Correction: Enhanced GAB2 Expression Is Associated With Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Amplification of the Ch19p13.2 NACC1 Locus in Ovarian High-Grade Serous Carcinoma
Modern Pathology
Forensic Medicine
Pathology
GLUT 1 Receptor Expression and Circulating Levels of Fasting Glucose in High Grade Serous Ovarian Cancer
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Integrated Analysis to Identify Molecular Biomarkers of High-Grade Serous Ovarian Cancer
OncoTargets and Therapy
Oncology
Pharmacology
VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma
Journal of Oncology
Oncology
